341 results on '"De Keyser, Filip"'
Search Results
2. Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
3. Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients
4. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal
5. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis
6. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
7. Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines
8. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
9. Management of inflammatory bowel disease in pregnancy
10. Novel autoantibody markers for early and seronegative rheumatoid arthritis
11. Hand Radiological Damage in Systemic Sclerosis: Comparison with a Control Group and Clinical and Functional Correlations
12. Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohort
13. An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases
14. Digital ulcers predict a worse disease course in patients with systemic sclerosis
15. The influence of ageing on the development and management of rheumatoid arthritis
16. Relevance of Different Results of Different Anti–Double-Stranded DNA Assays in Reporting Clinical Studies: Comment on the Article by Petri et al
17. Growth Differentiation Factor 15, a Marker of Lung Involvement in Systemic Sclerosis, Is Involved in Fibrosis Development but Is not Indispensable for Fibrosis Development
18. Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
19. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
20. Clinical observations programme in SpA: disease parameters, treatment options and practical management issues
21. Prevalence and management of drug interactions between nonsteroidal anti‐inflammatory drugs and antithrombotics in ambulatory care.
22. Gut inflammation in the spondyloarthropathies
23. Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis
24. The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies
25. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation
26. Gut inflammation and spondyloarthropathies
27. Anti-TNF-alpha therapy in ankylosing spondylitis
28. Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
29. Three-Year Follow-up of Rituximab in Rheumatoid Arthritis: Results From the Belgian MIRA (MabThera in Rheumatoid Arthritis) Registry.: 1305
30. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study
31. The Association of Illness Perceptions with Physical and Mental Health in Systemic Sclerosis Patients: An Exploratory Study
32. Work participation and work transition in patients with systemic sclerosis: a cross-sectional study
33. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use
34. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach
35. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
36. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions
37. Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective
38. Editorial
39. Vaccinations in patients with immune-mediated inflammatory diseases
40. Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
41. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study
42. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
43. Validation of a Manual Ability Questionnaire in Patients With Systemic Sclerosis
44. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
45. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
46. Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis
47. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis
48. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohnʼs disease
49. Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope
50. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.